Global Discovery Biosciences licensed Cleveland HeartLab Inc. exclusive rights to distribute its PULS (Protein Unstable Lesion Signature) cardiac test to physicians in the US. (Jul.)
GD Biosciences' PULS is a simple, non-invasive blood test designed to identify individuals with active but currently undetected subclinical coronary heart disease. It uses predictive markers and measures the body’s...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?